Company / Shareholders' Equity
PUMA BIOTECHNOLOGY, INC. Shareholders' Equity History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$92.1M
FY2025
5-year range
-$6.0M / $92.1M
FY2021-FY2025
Trend
+326.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +326% YoY in FY2025, a notable deviation from the 8-year average annual change of +135%.
Based on SEC 10-K filings.
$92M in FY2025 with a 5-year CAGR of +21.8%.
Improved from -$2M to $92M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +21.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- PUMA BIOTECHNOLOGY, INC.'s shareholders' equity has grown for 3 consecutive years.
- 5-year CAGR of +21.8%, indicating consistent growth.
- In FY2025, shareholders' equity increased 326.3% year-over-year.
- Peak shareholders' equity was recorded in FY2018.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $92.1M | +326.3% |
| FY2024 | $21.6M | +983.4% |
| FY2023 | -$2.4M | +58.9% |
| FY2022 | -$6.0M | -134.1% |
| FY2021 | $17.5M | -49.1% |
| FY2020 | $34.3M | -35.6% |
| FY2019 | $53.3M | -74.6% |
| FY2018 | $209.8M | +1.9% |
| FY2017 | $206.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026